1-cyclobutyl-N-[1-[(1S)-2,2-dimethylcyclopropyl]ethenyl]-6-methylbenzimidazol-2-amine;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3,3-dimethylbutanamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3-fluoro-3-methylcyclobutane-1-carboxamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3-methylbutanamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3,3,3-trifluoro-2,2-dimethylpropanamide;trans-(1S,2S)-N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-2-(2-hydroxypropan-2-yl)cyclopropane-1-carboxamide
C108H140F4N18O6 — CID 159212851
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-cyclobutyl-N-[1-[(1S)-2,2-dimethylcyclopropyl]ethenyl]-6-methylbenzimidazol-2-amine;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3,3-dimethylbutanamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3-fluoro-3-methylcyclobutane-1-carboxamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3-methylbutanamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3,3,3-trifluoro-2,2-dimethylpropanamide;trans-(1S,2S)-N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-2-(2-hydroxypropan-2-yl)cyclopropane-1-carboxamide
1-cyclobutyl-N-[1-[(1S)-2,2-dimethylcyclopropyl]ethenyl]-6-methylbenzimidazol-2-amine;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3,3-dimethylbutanamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3-fluoro-3-methylcyclobutane-1-carboxamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3-methylbutanamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3,3,3-trifluoro-2,2-dimethylpropanamide;trans-(1S,2S)-N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-2-(2-hydroxypropan-2-yl)cyclopropane-1-carboxamide (PubChem CID 159212851) has the molecular formula C108H140F4N18O6 and a molecular weight of 1862.42 g/mol. Its IUPAC name is 1-cyclobutyl-N-[1-[(1S)-2,2-dimethylcyclopropyl]ethenyl]-6-methylbenzimidazol-2-amine;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3,3-dimethylbutanamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3-fluoro-3-methylcyclobutane-1-carboxamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3-methylbutanamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3,3,3-trifluoro-2,2-dimethylpropanamide;trans-(1S,2S)-N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-2-(2-hydroxypropan-2-yl)cyclopropane-1-carboxamide.
Molecular Properties
| Compound Name | 1-cyclobutyl-N-[1-[(1S)-2,2-dimethylcyclopropyl]ethenyl]-6-methylbenzimidazol-2-amine;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3,3-dimethylbutanamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3-fluoro-3-methylcyclobutane-1-carboxamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3-methylbutanamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3,3,3-trifluoro-2,2-dimethylpropanamide;trans-(1S,2S)-N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-2-(2-hydroxypropan-2-yl)cyclopropane-1-carboxamide |
|---|---|
| PubChem CID | 159212851 |
| Molecular Formula | C108H140F4N18O6 |
| Molecular Weight | 1862.42 g/mol |
| Exact Mass | 1861.11 |
| IUPAC Name | 1-cyclobutyl-N-[1-[(1S)-2,2-dimethylcyclopropyl]ethenyl]-6-methylbenzimidazol-2-amine;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3,3-dimethylbutanamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3-fluoro-3-methylcyclobutane-1-carboxamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3-methylbutanamide;N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-3,3,3-trifluoro-2,2-dimethylpropanamide;trans-(1S,2S)-N-(1-cyclobutyl-6-methylbenzimidazol-2-yl)-2-(2-hydroxypropan-2-yl)cyclopropane-1-carboxamide |
| SMILES | C=C(Nc1nc2ccc(C)cc2n1C1CCC1)[C@H]1CC1(C)C.Cc1ccc2nc(NC(=O)C(C)(C)C(F)(F)F)n(C3CCC3)c2c1.Cc1ccc2nc(NC(=O)C3CC(C)(F)C3)n(C3CCC3)c2c1.Cc1ccc2nc(NC(=O)CC(C)(C)C)n(C3CCC3)c2c1.Cc1ccc2nc(NC(=O)CC(C)C)n(C3CCC3)c2c1.Cc1ccc2nc(NC(=O)[C@H]3C[C@@H]3C(C)(C)O)n(C3CCC3)c2c1 |
| InChI | InChI=1S/C19H25N3O2.C19H25N3.C18H22FN3O.C18H25N3O.C17H20F3N3O.C17H23N3O/c1-11-7-8-15-16(9-11)22(12-5-4-6-12)18(20-15)21-17(23)13-10-14(13)19(2,3)24;1-12-8-9-16-17(10-12)22(14-6-5-7-14)18(21-16)20-13(2)15-11-19(15,3)4;1-11-6-7-14-15(8-11)22(13-4-3-5-13)17(20-14)21-16(23)12-9-18(2,19)10-12;1-12-8-9-14-15(10-12)21(13-6-5-7-13)17(19-14)20-16(22)11-18(2,3)4;1-10-7-8-12-13(9-10)23(11-5-4-6-11)15(21-12)22-14(24)16(2,3)17(18,19)20;1-11(2)9-16(21)19-17-18-14-8-7-12(3)10-15(14)20(17)13-5-4-6-13/h7-9,12-14,24H,4-6,10H2,1-3H3,(H,20,21,23);8-10,14-15H,2,5-7,11H2,1,3-4H3,(H,20,21);6-8,12-13H,3-5,9-10H2,1-2H3,(H,20,21,23);8-10,13H,5-7,11H2,1-4H3,(H,19,20,22);7-9,11H,4-6H2,1-3H3,(H,21,22,24);7-8,10-11,13H,4-6,9H2,1-3H3,(H,18,19,21)/t13-,14-;15-;;;;/m01..../s1 |
| InChIKey | KQSDRLLOFMGMSP-KARGREPRSA-N |
| XLogP | 25.70 |
| TPSA | 284.68 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 136 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1862.42 |
| LogP ≤ 5 | 25.70 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 19 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159212851 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.